Escitalopram EP Impurity K (Free Base)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

128196-02-1Escitalopram EP Impurity K (Free Base)

● In Stock

Catalogue No.:VL1570018
CAS No.:128196-02-1
Mol. Formula:C20H21FN2O
Mol. Weight:324.39 g/mol

Additional information on CAS 128196-02-1

Parent drug

Escitalopram

IUPAC Name

(1R)-1-[3-(dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile

Synonyms

Citalopram R-Isomer

Pharmacopeial Synonyms

N/A

Smiles

CN(C)CCC[C@]1(C2=CC=C(F)C=C2)OCC3=C1C=CC(C#N)=C3

InChI

InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m1/s1

Description

Escitalopram EP Impurity K, also identified as Citalopram R-Isomer (CAS 128196-02-1), is a chiral enantiomeric impurity critical to escitalopram quality control. This impurity must be monitored within the impurity profile to ensure enantiomeric purity and compliance with ICH Q3A and Q3B guidelines. Analytical characterization typically employs chiral HPLC, LC-MS and NMR to quantify and confirm stereochemistry and related substance limits. Accurate referencing of Impurity K supports method validation, stability studies and batch release testing. Technical specification data, retention time, and acceptance criteria enable robust control strategies to minimize R-isomer content during synthesis and purification.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url